TP53 LOSS CREATES SUSCEPTIBILITY TO ANTI-POL II THERAPY IN COLORECTAL CANCER

被引：0
|
作者：
不详
机构：
来源：
CANCER DISCOVERY | 2015年 / 5卷 / 06期
关键词：
D O I：
10.1158/2159-8290.CD-RW2015-083
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：577 / 577
页数：1
相关论文
共 50 条
  • [11] TP53 codon 72 polymorphism and colorectal cancer susceptibility: a meta-analysis
    Wang, Jing-Jun
    Zheng, Yuan
    Sun, Liang
    Wang, Li
    Yu, Peng-Bo
    Dong, Jian-Hua
    Zhang, Lei
    Xu, Jing
    Shi, Wei
    Ren, Yu-Chun
    MOLECULAR BIOLOGY REPORTS, 2011, 38 (08) : 4847 - 4853
  • [12] TP53 codon 72 polymorphism and colorectal cancer susceptibility: a meta-analysis
    Jing-Jun Wang
    Yuan Zheng
    Liang Sun
    Li Wang
    Peng-Bo Yu
    Jian-Hua Dong
    Lei Zhang
    Jing Xu
    Wei Shi
    Yu-Chun Ren
    Molecular Biology Reports, 2011, 38 : 4847 - 4853
  • [13] TP53 haplotypes and susceptibility to breast cancer.
    Kristensen, Vessela
    Garcia-Closas, Montserrat
    Langerod, Anita
    Qi, Ying
    Yeager, Meredith
    Burdett, Laurie
    Welch, Robert
    Lissowska, Jolanta
    Peplonska, Beata
    Bardin-Mikolajczak, Alicija
    Brinton, Louise
    Gerhard, Daniela S.
    Perou, Charles
    Borresen-Dale, Anne-Lise
    Chanock, Stephen
    CANCER RESEARCH, 2006, 66 (08)
  • [14] TP53 variants and susceptibility to ovarian cancer in poland
    Garcia-Closas, Montserrat
    Burdett, Laurie
    Brinton, Louise
    Lissowska, Jolanta
    Sherman, Mark
    Yeager, Meredith
    Szeszenia-Dabrowska, Neonila
    Peplonska, Beata
    Welch, Robert
    Mikolajczak, Alicja Bardin
    Zatonski, Witold
    Qi, Ying
    Chanock, Stephen
    CANCER RESEARCH, 2006, 66 (08)
  • [15] A TP53 polymorphism is associated with increased risk of colorectal cancer and with reduced levels of TP53 mRNA
    Gemignani, F
    Moreno, V
    Landi, S
    Moullan, N
    Chabrier, A
    Gutiérrez-Enríquez, S
    Hall, J
    Guino, E
    Peinado, MA
    Capella, G
    Canzian, F
    ONCOGENE, 2004, 23 (10) : 1954 - 1956
  • [16] A TP53 polymorphism is associated with increased risk of colorectal cancer and with reduced levels of TP53 mRNA
    Federica Gemignani
    Victor Moreno
    Stefano Landi
    Norman Moullan
    Amélie Chabrier
    Sara Gutiérrez-Enríquez
    Janet Hall
    Elisabeth Guino
    Miguel Angel Peinado
    Gabriel Capella
    Federico Canzian
    Oncogene, 2004, 23 : 1954 - 1956
  • [17] TP53 mutations in Romanian patients with colorectal cancer
    Felix Manirakiza
    Hidetaka Yamada
    Yuji Iwashita
    Keiko Ishino
    Rei Ishikawa
    Zsolt Kovacs
    Eva Osvath
    Augustin Nzitakera
    Simona Gurzu
    Haruhiko Sugimura
    Genes and Environment, 45
  • [18] TP53 mutations in Romanian patients with colorectal cancer
    Manirakiza, Felix
    Yamada, Hidetaka
    Iwashita, Yuji
    Ishino, Keiko
    Ishikawa, Rei
    Kovacs, Zsolt
    Osvath, Eva
    Nzitakera, Augustin
    Gurzu, Simona
    Sugimura, Haruhiko
    GENES AND ENVIRONMENT, 2023, 45 (01)
  • [19] ROLE OF TP53 IN THE ANTI-TUMOR IMMUNE RESPONSE AGAINST COLORECTAL CANCER
    Larafa, Imen
    Thoma, Oana-Maria
    Neurath, Markus
    Waldner, Maximilian
    GASTROENTEROLOGY, 2024, 166 (05) : S674 - S674
  • [20] TP53 mutations and loss of heterozygosity of chromosome 17 in colorectal tumors
    Yamamoto, L
    Lopes, AA
    HarbGama, A
    Nagai, MA
    BRAZILIAN JOURNAL OF GENETICS, 1996, 19 (04): : 647 - 653
12345